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Original ArticleModified Rankin Scale and Short-Term Outcome in Cranial Neurosurgery:A Prospective and Unselected Cohort StudyElina Reponen1, Hanna Tuominen1, Juha Hernesniemi2, Miikka Korja2-BACKGROUND: The modified Rankin Scale (mRS) was
developed to monitor functional recovery after stroke, but
nowadays it is a treatment outcome measure in elective
neurosurgery. Our objective was to study how mRS
changes associate with short-term postoperative outcome.
-METHODS: Preoperative, in-hospital, and 30-day mRS
scores came from a prospective, consecutive and unse-
lected cohort of 418 adult elective craniotomy patients
enrolled between December 2011 and December 2012 in
Helsinki, Finland. Recorded data included subjective and
objective postoperative in-hospital complications as well
as changes in mRS score after surgery.
-RESULTS: Minor or major complications were detect-
able in 46% of the patients. In-hospital and 30-day post-
operative increases in mRS score were inconsistent;
among patients with no complications, 17% had a greater
mRS score at discharge and 24% at 30 days, whereas 28% of
the patients with major complications showed no increase
in mRS score at discharge. Of individual complications,
only new or worsened hemiparesis, silent stroke, and
pneumonia were associated with postoperative increase
(>2) in mRS score after multivariable analysis. For mRS-
score difference > 1 at discharge in detecting major com-
plications (including mortality), sensitivity was 45% and
specificity 94%.
-CONCLUSIONS: The mRS changes after elective cranial
neurosurgery are inconsistent. The mRS seems to represent
functional changes, which do not necessarily associate
with detected in-hospital complications.Key words
- Craniotomy
- modified Rankin Scale
- Outcome
Abbreviations and Acronyms
ARUBA: A Randomized Trial of Unruptured Brain Arteriovenous Malformation
ISUIA: International Study of Unruptured Intracranial Aneurysms
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WORLD NEUROSURGERY 91: 567-573, JULY 2016INTRODUCTIONhe modified Rankin Scale (mRS) originally was developed
in the 1950s for the assessment of functional outcome inTpatients recovering from neurological deficits caused by a
spontaneous stroke.1 In the late 1980s, the mRS was modified to
its current form of a 7-tier classification, in which 0 represents
an asymptomatic and 6 a deceased patient.2 In clinical practice,
the mRS is a simple and widely applicable scale, and its
interrater variability is low.3-5 Neurosurgical society has adopted
the mRS to assess outcomes after various neurosurgical treat-
ments. Postoperative mRS scores are suggested to represent sur-
gical outcome in cranial tumor surgery,6-8 and perhaps even more
so in cerebrovascular surgery.9-26
As an example of a widespread use of mRS in neurosurgery, most
influential studies on cerebrovascular surgery, such as the first ran-
domized treatment trial of unruptured brain arteriovenous malfor-
mations (A Randomized Trial of Unruptured Brain Arteriovenous
Malformation [ARUBA]),25 the International Study of Unruptured
Intracranial Aneurysms (ISUIA),26 and the International
Subarachnoid Aneurysm Trial (ISAT)22-24 have each reported out-
comes and compared treatment results by the mRS. In the ARUBA
and the ISUIA studies the mRS was assessed at postoperative follow-
up visits or telephone contactswhereas in the ISATstudy themRSwas
assessed using a mailed questionnaire adapted from Lindley and
colleagues.27 A number of other outcome scores also are available in
neurosurgery. For example, the Glasgow Outcome Scale is used for
patients with brain injury/trauma28 and the Karnofsky Performance
Score29 or Eastern Cooperative Oncology Group Performance Status
score30 for patients with brain tumors. These scores are only
applicable for specific patient subgroups, however, unlike the mRS
with its wide use in cranial neurosurgery.
In this prospective and unselected cohort study, we attempted to
define the role of the mRS, recorded with methods similar to the
ISUIA and ARUBA, in detecting various short-term outcomes inFrom the Departments of 1Anaesthesiology, Intensive Care and Pain Medicine, and
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ELINA REPONEN ET AL. MRS AND SHORT-TERM OUTCOME IN CRANIAL NEUROSURGERYelective cranial neurosurgery. Specifically, our aimwas to determine
which complications cause changes in postoperative mRS scores
and whether postoperative changes in mRS scores represent the
overall short-term surgical outcome of elective craniotomy patients.
MATERIALS AND METHODS
Ethical Statement
The Ethics Committee of the Hospital District of Helsinki and
Uusimaa reviewed and approved the study. All subjects gave their
written informed consent before enrollment.
Study Population and Data Collection
The cohort comprised consecutive and unselected adult patients
(18 years) who underwent elective intracranial surgeries in Hel-
sinki University Hospital between December 7, 2011, and December
31, 2012. The enrollment protocol has been described in a previous
article.31 Data collection included patient-reported health-related
data collected through 2 questionnaires (1 preoperatively and 1 at
hospital discharge), tailored for the purposes of this study. To
minimize surgeon-related interpretation bias, a study anesthesiol-
ogist recorded the mRS score for each patient. In addition, the
study anesthesiologist systematically recorded additional data on in-
hospital complications and unplanned reoperations within 30
postoperative days. If the patient was still hospitalized on day 30,
hospital discharge data also were recorded on day 30. For patients
who were discharged and readmitted for an unplanned reoperation
within the 30-day follow-up, the hospital discharge data were
recorded at initial discharge. Hospital databases and the Population
Register Center were checked for confirming mortality figures (in-
hospital and 30-days). A more detailed description of data collection
is available in an online supplement.
Postoperative Complications
Postoperative in-hospital major complications comprised mortal-
ity, new or worsened hemiparesis, silent stroke (radiological
finding without clinical symptoms), deep-vein thrombosis, pul-
monary embolism, acute myocardial infarction, and pneumonia.
The hemipareses were recorded at discharge, but other major
complications at any time during the hospital stay. Unplanned
recraniotomies or endovascular interventions within 30 post-
operative days also were considered major complications.
Recorded minor complications included subjective visual dis-
turbances, minor infections, new or worsened facial nerve palsies,
wound infections, meningitis (no neurological deterioration),
subjective dysphagia, dysphasia/dysarthria, and unplanned cranial
minor reoperations such as ventriculostomy and wound revision in
the operating room (OR). These reoperations did not include
tracheostomy, extracranial reoperations, or reoperations per-
formed outside the OR (bedside). In-hospital complications data
were retrieved from three sources: patient questionnaires, study
forms filled by study anesthesiologists at hospital discharge, and
hospital patient records.
mRS Assessments
The mRS score was recorded on admission, at discharge, and at 30
days after surgery. A face-to-face assessment occurred on admis-
sion and at discharge, whereas a structured telephone interview568 www.SCIENCEDIRECT.com WORLD NEUwas used at 30 days.3 The difference between the preoperative and
postoperative mRS scores received the designation “mRS-score
difference.”
Statistical Analyses
For association analyses between mRS score and specific com-
plications, we assigned each patient to one complication pheno-
type. Patients identified as having only one complication
underwent separate association analyses. Ranking the significance
of complications was done using Pearson chi-square test-based
univariable analyses of all complications with mRS-score differ-
ence >2 between hospital discharge and preoperative mRS-scores.
Significant (P values <0.05) complications in the univariable an-
alyses were entered into logistic regression multivariable analysis,
and the most significant complications were ranked in order. All
statistically nonsignificant major and minor complications were
ranked in order by frequency. This ranking order of complication
phenotypes enabled assigning one patient to only one complica-
tion phenotype, when this was needed in further statistical ana-
lyses. Two-way (2  2) contingency tables provided means for
sensitivity, specificity, and positive predictive value and negative
predictive value calculations. The corresponding author (E.R.)
conducted the statistical analyses with the IBM SPSS Statistics for
Windows and Mac OX, Version 21.0 (IBM, Corp., Armonk, New
York, USA).
RESULTS
Study Cohort and Craniotomies
Of the 418 study patients, 260 (62%) were female. Mean and
median ages were 56.4 and 58.0 years (range 1887). Surgical
indications included vascular lesions (intracranial aneurysm or
arteriovenous malformation) for 138 (33%), benign tumors for 134
(32%), and malignant tumors for 121 (29%) patients. One-quarter
(25%) of the craniotomies were infratentorial.
In-Hospital Complications and 30-Day Mortality
Table 1 shows the recorded individual complications and the
frequency of their combinations. The rates of individual
complications have been described previously.32 Of 418 patients,
194 (46%) had 1 or more in-hospital complications. Of the 194
patients, only 1 complication occurred in 120 (62%), whereas the
remaining 38% (73 patients) had multiple complications. Four
patients (1%) died (mRS ¼ 6) in the hospital. The 30-day mortality
rate was 2% (10 patients). One patient who died in the hospital
had no recorded major or minor complications, but massive
pulmonary embolism emerged in the autopsy.
Major Complications. In-hospital deaths excluded, the rate of major
complications was 18%. The number of sole major complications
was limited (35 of 76 patients). The three most frequent in-
hospital major complications were new or worsened hemiparesis
(10%), unplanned recraniotomy or endovascular intervention
(4%), and pneumonia (3%).
Minor Complications. One or more in-hospital minor complications
occurred in 159 (38%) of the surgical patients, of whom 118 (74%)
had no major complications at all. The 3 most frequent minorROSURGERY, http://dx.doi.org/10.1016/j.wneu.2016.03.102





Stroke Pneumonia AMI PE DVT SVD Speech
Minor
Infections Dysphagia N. facialis WI/Meningitis
Unplanned Minor
Cranial Reoperation
Hemi 41 3 0 4 0 1 0 8 11 5 4 7 2 1
Unplanned re-CRT or EI 3 17 0 0 0 0 0 1 3 4 1 1 2 1
Silent stroke 0 0 6 2 1 0 0 3 2 2 1 0 1 0
Pneumonia 4 0 2 14 2 0 0 2 3 4 3 0 2 1
AMI 0 0 1 2 4 0 0 1 1 1 0 1 0 0
PE 1 0 0 0 0 3 0 0 0 1 0 0 0 0
DVT 0 0 0 0 0 0 2 0 0 0 0 0 0 0
SVD 8 1 3 2 1 0 0 76 13 9 11 5 2 0
Speech 11 3 2 3 1 0 0 13 49 5 9 7 0 0
Minor infections 5 4 2 4 1 1 0 9 5 39 2 1 2 0
Dysphagia 4 1 1 3 0 0 0 11 9 2 26 2 2 0
N. facialis 7 1 0 0 1 0 0 5 7 1 2 14 0 0
WI/meningitis 2 2 1 2 0 0 0 2 0 2 2 0 9 0
Unplanned minor cranial
reoperation
1 1 0 1 0 0 0 0 0 0 0 0 0 3
































































































































ELINA REPONEN ET AL. MRS AND SHORT-TERM OUTCOME IN CRANIAL NEUROSURGERYcomplications comprised subjective postoperative visual distur-
bance (18%), dysphasia/dysarthria (12%), and minor infections
(9%).
Unplanned Reoperations. The rate of unplanned reoperations
(including minor operations involving the head) was 5%: of these
19 patients; 16 underwent recraniotomy, 1 had an endovascular
intervention, and 3 had minor cranial reoperations in the OR (2
ventriculostomies and 1 wound revision). In multivariable analysis
for the assignment of individual complication phenotypes, only
new hemiparesis (P < 0.001), silent stroke (P < 0.001), and
pneumonia (P ¼ 0.005) were associated with postoperative mRS-
score difference >2.22
22

































Figure 1. Numbers and percentages of patients with hospital di
2 or >2 in subgroups with or without recorded minor comp
major complications including mortality recorded at discharge
570 www.SCIENCEDIRECT.com WORLD NEUPreoperative and Postoperative mRS
Supplementary Table 1 depicts mRS scores in patient subgroups.
Preoperative mRS scores were available for 417 patients. The
median preoperative mRS score was 1 (range 05). On
admission, 374 (90%) patients were functionally independent
(mRS score <3), and 267 (64%) had no significant functional
symptoms (mRS score 0e1). For 12 patients (no deaths included),
mRS score was not recorded at discharge, and thus mRS score
was available for 406 patients (median 1, range 06, deaths
included) at discharge. The number of patients with mRS score
>2 doubled postoperatively as 92 (23%) patients had mRS score
>2 at discharge. The rates of mRS scores 2 and >2 in various
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preoperave to hospital discharge
mRS no change or decreased mRS increased
preoperave mRS 0-1 (n=258) preoperave mRS >2 (n=42)
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mortality mortality
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preoperave to 30 days
mRS no change or decreased mRS increased
preoperave mRS 0-1 (n=223) preoperave mRS >2 (n=32)
yes no      yes     no      yes     no                yes     no      yes     no      yes     no
major            major          minor
incl.               excl.
mortality mortality
major             major          minor
incl.               excl.
mortality mortality
Complicaons                                                 Complicaons
Figure 2. Numbers and percentages of patients with decreased/no change or increase in modified Rankin Scale (mRS)
score differences at hospital discharge and at 30 days and the rate of complications in subgroups with minor or no
preoperative functional disability (mRS score 0e1) and preoperative functional dependence (mRS score >2). incl.,
including; excl., excluding.
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interview. Including the 10 patients who died within 30 days after
surgery, a total of 350 patients were included in the 30-day ana-
lyses. At 30 days, 267 (76%) of these patients were functionally
independent (mRS score <3), and the median mRS score was 1.
mRS Score Differences and Complications
For the differences between preoperative and postoperative mRS
scores, data were available for 405 patients at discharge and 349 at
the 30-day follow-up. Figure 2 summarizes mRS-score differences
between preoperative and postoperative mRS scores in patients
with no or minor (mRS ¼ 01) preoperative functional disability,
as well as in preoperatively dependent (mRS score >2) patients.
Overall, 138 (34%) and 54 (13%) patients had mRS-score differ-
ences >0 and >1 at discharge, respectively. Of 216 patients with
no recorded in-hospital complications, mRS scores at discharge
increased in 37 (17%). Especially patients with preoperative mRS
scores 0 or 1 appeared to have deteriorating mRS scores at
discharge without any objective complications (Figure 2).
Additionally, 41 (55%) of 75 patients with major in-hospital
complications (including mortality) did not have an mRS-score
difference >1 at discharge (Supplementary Table 2).
At 30 days, 126 (36%) and 57 (16%) of the 349 patients had
respective mRS score differences of >0 and >1. Interestingly,
mRS scores worsened from discharge to 30 days in 45 (24%) of the
189 patients with no in-hospital complications. From discharge to
30 days, mRS scores improved in 101 (29%) of 349 patients and
remained unchanged in 122 (35%). Anecdotally, 39 (42%) of 92
patients without preoperative functional impairments (mRS
score ¼ 01) and without in-hospital complications reported
increased mRS scores at 30 days.
Two-thirds (66%) of the patients with the greatest ranked
complication phenotype (new hemiparesis) had other major or
minor complications as well. An mRS score worsening at 30 days
was associated with the composite complication outcome mea-
sures, that is, the major (P < 0.001) and minor (P ¼ 0.030)
complications; however, the sensitivity, specificity, positive pre-
dictive value, and negative predictive value of the mRS-score dif-
ferences, even for major and minor complications, were poor
(Supplementary Table 3).
DISCUSSION
Nearly one-fifth of patients without any complications had
increased mRS scores at discharge, and approximately three-fifths
with minor complications had no mRS-score increase at all. At 30
postoperative days, the correlation further weakened, as one-fourth
of the patients without complications had an mRS score difference
>0. As only 35% of these patients underwent surgery for malignant
intracranial tumors, neither early progression of the disease nor
postoperative tumor treatment explain this observed trend.
In outcome and treatment comparisons, mRS-based outcome
often is dichotomized into good (mRS 2) and poor (mRS >2).
One-fifth (20%) of the cerebrovascular and one-fourth (25%) of all
tumor patients had mRS scores >2 at discharge in our study. Of
all these patients, roughly one-third (35%) already had an mRS
score >2 preoperatively. Most surprisingly, only 57% of all pa-
tients with mRS score >2 at discharge had major complications.572 www.SCIENCEDIRECT.com WORLD NEUThe underlying reasons for the unpredictability of periopera-
tive changes in the mRS scores with regard to recorded
complications are probably complex. The possible effect of
postoperative pain or fatigue may have led to perioperative loss
of function (mRS-score difference >0) even in the absence of
major complications, especially in the subgroup of patients who
had none or mild symptoms preoperatively (mRS score 0e1). We
have found previously that dependent functional status (mRS
score 3) at 30 days associates with both patient-reported
postoperative deterioration in subjective functional status as
well as with patient-reported poor overall health.33 Moreover,
patients with preoperative mRS scores 0 and 1 may experience
undefined functional impairments even without an objective
evidence of postoperative complications as suggested by the
presented results. In contrast, patients with high preoperative
mRS scores may experience no changes in their well-being and
functionality even after serious complications. In brief, post-
operative functional changes in mRS are often unassociated with
objectively recorded complications. Because psychosocial and
cognitive factors may play a role in subjective postoperative
functional status, the use of mRS as a surgical outcome measure
is perhaps questionable.
Strengths and Limitations of the Study
The strengths of this unselected cohort study include its prospective
design with tailored postoperative adverse event recording. More-
over, mRS scores were assessed by anesthesiologists who are un-
likely to have any bias in reporting surgical outcome. Furthermore,
mRS assessment protocol was similar to the ARUBA and ISUIA. In
the ARUBA study,mRS scores were recorded at baseline and at each
follow-up visit or telephone contact. In the ISUIA study, the mRS
was recorded at each follow-up visit which were scheduled at 7 days,
at discharge, at 30 days, and then at yearly intervals. The study has a
number of limitations. First, a selection bias cannot be excluded,
because only 76% of all eligible patients participated in the study.
Second, the interrater variability of the mRS is relatively low3-5 but
cannot be excluded. Third, the response rate for the 30-day tele-
phone interview was only 81%. We performed a posthoc analysis of
the dropout effect relying on the outpatient hospital records, but the
results remained unchanged (results not shown). Fourth, silent
strokes were included in major complications, even though they are
not expected to affect the functional status. When the analyses were
repeated excluding the silent strokes, however, the results remained
unchanged (results not shown). Fifth, our follow-up can be
considered short. However, if mRS score does not change during
short-term follow-up, or changes even without any observed com-
plications, it is unlikely that a long-term follow-up would provide
more reliable results. Sixth, the methods of measuring post-
operative mRS differed at discharge (anesthesiologist’s objective
assessment) and at 30 days (patient’s subjective reporting in a
structured telephone interview), and subjectivity in the 30-day mRS
scores cannot be excluded.
CONCLUSIONS
The mRS reflects the rate of postoperative hemiparesis to some
extent, but hemiparesis only accounts for a small fraction of
complications in cranial neurosurgery. The mRS score differencesROSURGERY, http://dx.doi.org/10.1016/j.wneu.2016.03.102
ORIGINAL ARTICLE
ELINA REPONEN ET AL. MRS AND SHORT-TERM OUTCOME IN CRANIAL NEUROSURGERYassociate poorly with the described complications in modern
elective cranial neurosurgery, even if it measures subjectiveWORLD NEUROSURGERY 91: 567-573, JULY 2016functional changes. The neurosurgical community could benefit
from a consensus on more objective outcome measurements.34REFERENCES
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Patient-reported data were collected with tailored patient question-
naires. If the patient was unable to read orwrite because ofmedical or
age-related issues such as problems in eyesight, the data were
collected through a personal interview during the preoperative visit.
Preoperative nurses and study anesthesiologists provided help if the
patient had difficulties in completing the questionnaires. The pre-
operative patient questionnaire consisted of the following questions:
1. Basic information:
- Name
- Social security number
- Date of filling the questionnaire
- Planned date for operation
- Age
- Weight, height
- Place of residence before the operation (home, hospital,
assisted residency, health care center, nursing home)




- Chronic lung illness
- Atherosclerosis, carotid artery stenosis, claudication
- Deep-vein thrombosis, pulmonary embolism, thrombogenic
condition




- Other significant illness




- Yes, how many cigarettes/day, how many years?
- Stopped smoking, how many cigarettes/day, how many
years, when stopped?
5. Alcohol consumption during past 7 days
- None
- Moderate: women 1e16 doses, men 1e24 doses
- Excessive: women over 16 doses, men over 24 doses
6. How often do you exercise for at least 20 minutes, enough to
feel short of breath and break a sweat?
- Cannot exercise because of illness or condition
- Less often than once a week
- Once a week
- 2e3 times a week
- 4 times a week or more
7. How do you rate your physical fitness at the moment (excellent-
good-average-poor-very poor)?
8. Can you climb to flights of stairs without stopping?
- Yes
- No, why?
Additionally, the patients were asked to fill a self-administered
test for the detection of cognitive dysfunction called Test Your
Memory (TYM).1
Anesthesiologist-Filled Study Form and Hospital Patient Records
At the time of the preoperative consultation, a study anesthesi-
ologist filled a study form on each patient. Information was
retrieved from hospital databases as necessary. If blood pressure
and heart rate were not measured at preoperative consultation, we
used the first measurements in the OR before the beginning of the
anesthesia. The recorded data comprised:
- Date of operation





- Body mass index (kg/m2)
- Use of anticoagulant medication
- Use of antithrombotic medication
- Preoperative blood pressure (mm Hg) and heart rate (beats per
minute)
- Routine preoperative laboratory tests
B hemoglobin (g/L)
B thrombocyte count (109/L)
B creatinine (mmol/L)
B blood glucose (mmo/L) (not fasting)
B Partial thromboplastin time (%)
B C-reactive protein (mg/L)
B Sodium (mmol/L)
B Potassium (mmol/L)
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- Charlson comorbidity score2
- American Society of Anesthesiologists physical status score3
- Helsinki American Society of Anesthesiologists score4
- modified Rankin Scale (mRS) score5,6
- Preoperative neurological symptoms
INTRAOPERATIVE DATA
Hospital Patient Records and Operating Room Management
System Database
Recorded intraoperative variables from hospital patient records
and operating room management system database included:
- Experience of the neurosurgeon
B resident
B specialist
- Experience of the anesthesiologist
B resident
B specialist
- Location of craniotomy
B infratentorial
B supratentorial





- Positioning during surgery
B supine
B prone
B lateral park-bench position
B sitting
B other (supine with head elevated)
- Duration (min) of surgery from first surgical intervention (begin-
ning of sterile skin preparation) to completion of wound dressings
- Duration (min) of anesthesia from first injection of an anesthetic
agent to extubation or transfer to the intensive care unit (ICU)
- Time of extubation
B in the operating room (OR)
B in the ICU less than 6 hours after leaving the OR
B in the ICU more than 6 hours after leaving the OR
- Blood loss during surgery (mL)
- Choice of anesthetic agent
B intravenous (propofol)
B volatile (sevoflurane or isoflurane)
B both
- Use of nitrous oxide (yes or no)
IN-HOSPITAL DATA
Patient-Reported Data
Patients filled a second questionnaire on postoperative symptoms
postoperatively at the neurosurgical ward. As with the preoperative
questionnaire, they were assisted as necessary. The postoperative
questionnaire included the following questions:
1. Basic information
- Name
- Social security number
2. Postoperative information
- Date of operation
- Date of hospital discharge (from Department of
Neurosurgery)
- Place of residence after hospital discharge (home, hospital,
assisted residency, health care center, nursing home)
3. Postoperative neurological deficits/symptoms
- Short description of symptoms
4. Postoperative symptoms (No/Yes, what?)
- Postoperative visual impairment
- Speaking difficulties (dysphasia, aphasia)
- Swallowing difficulties (dysphagia)
- Local wound infection, meningitis
- Other infections




5. Do you think your functional status has changed after the
operation (No/Yes, how?)
Additionally, the patients filled a postoperative TYM test form,
identical to the preoperative test.
Hospital Patient Records
Hospital patient records provided data on in-hospital complica-
tions. A study anesthesiologist manually extracted the following
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B new or worsened facial nerve palsy
B subjective visual disturbances
B dysphasia/dysarthria
B dysphagia
B Reoperations involving the brain and their indications
- recraniotomy or endovascular intervention
- minor cranial reoperation
- length of stay in the ICU
- Hemoglobin on first postoperative day
HOSPITAL DISCHARGE DATA
Anesthesiologist-Filled Study Form and Hospital Patient Records
At the time of hospital discharge, a study anesthesiologist filled a
second study form. Hospital databases provided additional data as
necessary. The data collected at hospital discharge included:
- LOS in hospital
- New or worsened hemiparesis at hospital discharge




Telephone Interview, Hospital Patient Records, and Population
Register Center Database
At 30 postoperative days, a study anesthesiologist conducted a
structured telephone interview for each study patient. At least 3
attempts to reach the patient were made. The structured telephone
interview consisted of the following questions:
1. Basic information
- Patient name
- Social security number
- Date of call
2. Place of residence at the time of the interview (home, hospital,
assisted residency, health care center, nursing home)
3. 30-day mRS according to a validated mRS telephone
questionnaire7
4. How do you rate your general health at the moment (excellent-
good-average-poor-very poor)?
5. Do you have any persisting postoperative symptoms? (No/Yes,
what?) Are they severe/mild?
6. Which of the following best describes your overall satisfaction
in the neurosurgical care during this hospitalization? Excellent,
good, satisfactory, poor, or very poor.
A study anesthesiologist manually extracted data on reopera-
tions involving the brain for the time period between hospital
discharge and the end of 30-day follow-up.
The Population Register Center database provided mortality
data for all study patients at 30-day follow-up.
MISSING DATA
Complete data were unavailable for some patients. Patient
questionnaires and study forms were incompletely filled or not
returned in 119 cases (28.5%). Objective variables, such as in-
hospital complications were manually extracted from patient
records as necessary. Thus, complete in-hospital complications
data was available for all study patients. A total of 68 patients
(16.3%) were lost to follow-up at 30 days. We obtained the 30-day
mRS scores for 62 patients lost to follow-up for post hoc
analyses.
573.e3 www.SCIENCEDIRECT.com WORLD NEUROSURGERY, http://dx.doi.org/10.1016/j.wneu.2016.03.102
ORIGINAL ARTICLE
ELINA REPONEN ET AL. MRS AND SHORT-TERM OUTCOME IN CRANIAL NEUROSURGERY
Supplementary Table 1. Preoperative, Hospital Discharge, and 30-Day mRS Values
mRS
Infratentorial,
n [ 104 (%)
Supratentorial,
n [ 313 (%)
Vascular,
n [ 138 (%)
Benign Tumor,
n [ 135 (%)
Malignant Tumor,
n [ 120 (%)
Other Indications,
n [ 24 (%)
Women, n [
260 (%)
Men, n [ 157
(%)
‡65 years,
n [ 124 (%)
<65 years,
n [ 293 (%)
Preoperative,
n ¼ 417
0 21 (20.2) 86 (27.5) 59 (42.8) 33 (24.4) 13 (10.8) 2 (8.3) 72 (27.7) 35 (22.3) 20 (16.1) 87 (29.7)
1 39 (37.5) 119 (38.0) 44 (31.9) 62 (45.9) 43 (35.8) 9 (37.5) 98 (37.7) 60 (38.2) 41 (33.1) 117 (39.9)
2 29 (27.9) 80 (25.6) 30 (21.8) 29 (21.5) 39 (32.5) 11 (45.8) 67 (25.8) 42 (26.8) 37 (29.8) 72 (24.6)
3 8 (7.7) 19 (6.1) 3 (2.2) 6 (4.4) 16 (13.3) 2 (8.3) 13 (5.0) 14 (8.9) 17 (13.7) 10 (3.4)
4 6 (5.8) 7 (2.2) 1 (0.7) 3 (2.2) 9 (7.5) 0 (0.0) 8 (3.1) 5 (3.2) 6 (4.8) 7 (2.4)
5 1 (1.0) 2 (0.6) 1 (0.7) 2 (1.5) 0 (0.0) 0 (0.0) 2 (0.8) 1 (0.6) 3 (2.4) 0 (0.0)
Infratentorial,
n [ 98 (%)
Supratentorial,
n [ 308 (%)
Vascular,
n [ 133 (%)
Benign Tumor,
n [ 132 (%)
Malignant Tumor,
n [ 118 (%)
Other Indications,
n [ 23 (%)
Women,
n [ 255 (%)
Men,
n [ 151 (%)
‡65 years,
n [ 120 (%)
<65 years,




0 22 (22.4) 125 (40.6) 57 (42.9) 49 (37.1) 31 (26.3) 10 (43.5) 98 (38.4) 49 (32.5) 27 (22.5) 120 (42.0)
1 19 (19.4) 72 (23.4) 37 (27.8) 27 (20.5) 23 (19.5) 4 (17.4) 61 (23.9) 30 (19.9) 21 (17.5) 70 (24.5)
2 24 (24.5) 52 (16.9) 12 (9.0) 28 (21.2) 30 (25.4) 6 (26.1) 46 (18.0) 30 (19.9) 26 (21.7) 50 (17.5)
3 13 (13.3) 27 (8.8) 15 (11.3) 10 (7.6) 12 (10.2) 3 (13.0) 20 (7.8) 20 (13.2) 22 (18.3) 18 (6.3)
4 12 (12.2) 24 (7.8) 10 (7.5) 9 (6.8) 17 (14.4) 0 (0.0) 21 (8.2) 15 (9.9) 12 (10.0) 24 (8.4)
5 7 (7.1) 5 (1.6) 2 (1.5) 6 (4.5) 4 (3.4) 0 (0.0) 6 (2.4) 6 (4.0) 8 (6.7) 4 (1.4)
6 1 (1.0) 3 (1.0) 0 (0.0) 3 (2.3) 1 (0.8) 0 (0.0) 3 (1.2) 1 (0.7) 4 (3.3) 0 (0.0)
Infratentorial,
n [ 84 (%)
Supratentorial,




n [ 106 (%)
Malignant Tumor,
n [ 107 (%)
Other Indications,
n [ 24 (%)
Women, n [
219 (%)
Men, n [ 131
(%)
‡65 years,
n [ 105 (%)
<65 years,
n [ 245 (%)
At 30 days,
n ¼ 350
0 20 (23.8) 90 (33.8) 43 (38.1) 33 (31.1) 25 (23.4) 9 (37.5) 70 (32.0) 40 (30.5) 31 (29.5) 79 (32.2)
1 19 (22.6) 92 (34.6) 37 (32.7) 35 (33.0) 28 (26.2) 11 (45.8) 73 (33.3) 38 (29.0) 26 (24.8) 85 (34.7)
2 20 (23.8) 26 (9.8) 12 (10.6) 23 (21.7) 8 (7.5) 3 (12.5) 29 (13.2) 17 (13.0) 8 (7.6) 38 (15.5)
3 12 (14.3) 44 (16.5) 17 (15.0) 8 (7.5) 30 (28.0) 1 (4.2) 32 (14.6) 24 (18.3) 23 (21.9) 33 (13.5)
4 6 (7.1) 5 (1.9) 3 (2.7) 1 (0.9) 7 (6.5) 0 (0.0) 6 (2.7) 5 (3.8) 5 (4.8) 6 (2.4)
5 3 (3.6) 3 (1.1) 1 (0.9) 2 (1.9) 3 (2.8) 0 (0.0) 5 (2.3) 1 (0.8) 3 (2.9) 3 (1.2)
6 4 (4.8) 6 (2.3) 0 (0.0) 4 (3.8) 6 (5.6) 0 (0.0) 4 (1.8) 6 (4.6) 9 (8.6) 1 (0.4)
































































































































Supplementary Table 2. Preoperative mRS Compared with In-Hospital and 30-day mRS


















































None 85 131 73 116 94 122 71 118 37 179 45 144 8 208 16 173
Major, including mortality 5 70 5 50 16 59 15 40 54 21 35 20 34 41 17 38
Major, excluding mortality 5 69 5 49 16 58 15 39 53 21 34 20 34 40 17 37
Minor 29 93 24 84 42 80 36 72 51 71 48 60 14 108 24 84
Complication phenotypes
Hemi 2 38 4 25 5 35 9 20 33 7 16 13 22 18 8 21
Silent stroke 0 6 0 4 1 5 0 4 5 1 4 0 4 2 2 2
Pneumonia 0 8 0 4 0 8 0 4 8 0 4 0 2 6 3 1
Re-CRT/EI 3 11 1 10 8 6 4 7 3 11 6 5 3 11 1 10
AMI 0 2 0 2 0 2 1 1 2 0 1 1 2 0 1 1
PE 0 2 0 2 1 1 1 1 1 1 1 1 1 1 0 2
DVT 0 2 0 2 1 1 0 2 1 1 2 0 0 2 2 0
SVD 14 45 8 47 18 41 23 32 27 32 24 31 7 52 12 43
Speech 7 18 8 15 7 18 6 17 11 14 9 14 2 23 5 18
Minor infections 6 13 5 11 6 13 3 13 7 12 8 8 1 18 6 10
Dysphagia 0 7 1 6 6 1 3 4 1 6 3 4 1 6 1 6
N. facialis 0 2 0 2 2 0 1 1 0 2 1 1 0 2 0 2
WI/meningitis 1 1 1 1 0 2 0 2 1 1 1 1 1 1 0 2
Cranial minor reoperation 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sole complications
Hemi 1 13 2 9 2 12 2 9 11 3 7 4 7 7 2 9
Silent stroke 0 1 0 1 0 1 0 1 1 0 1 0 1 0 1 0
Pneumonia 0 3 0 3 0 3 0 3 3 0 3 0 0 3 2 1
Re-CRT/EI 2 6 0 8 5 3 4 4 1 7 4 4 1 7 1 7








































































































































PE 0 1 0 1 0 1 1 0 1 0 0 1 1 0 0 1
DVT 0 2 0 2 1 1 0 2 1 1 2 0 0 2 2 0
SVD 11 29 5 32 12 28 15 22 17 23 17 20 4 36 9 28
Speech 6 10 7 7 5 11 3 11 5 11 4 10 0 16 2 12
Minor infections 6 13 5 11 6 13 3 13 7 12 8 8 1 18 6 10
Dysphagia 0 7 1 6 6 1 3 4 1 6 3 4 1 6 1 6
N. facialis 0 2 0 2 2 0 1 1 0 2 1 1 0 2 0 2
WI/meningitis 1 1 1 1 0 2 0 2 1 1 1 1 1 1 0 2
Minor cranial reoperation 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
mRS score difference <0 indicates functional improvement after surgery and mRS score difference ¼ 0 implies the functional status has been unaffected by the surgery, mRS-score differences >0 and >1 indicate a decline in functional
capacity after surgery. Complications are recorded at discharge.

































































































































Supplementary Table 3. Sensitivity, Specificity, Positive Predictive Value, and Negative Predictive Value of mRS Score Differences >0 and >1 at Hospital Discharge and at
30-Day Follow-Up for Composite Complication Groups, Complication Phenotypes, and Patients Each with a Sole Complication
mRS Score Difference>0 mRS Score Difference >1
Discharge, n [ 405 30 days, n [ 349 Discharge, n [ 405 30 days, n [ 349
Sens. (%) Spec. (%) PPV (%) NPV (%) Sens. (%). Spec. (%) PPV (%) NPV (%) Sens. (%) Spec. (%) PPV (%) NPV (%) Sens. (%) Spec. (%) PPV (%) NPV (%)
Complication groups
None 17.1 46.6 26.8 33.0 23.8 49.4 35.7 35.4 3.7 75.7 14.8 40.7 8.5 74.4 28.1 40.8
Major, incl. mortality 72.0 74.5 39.1 92.1 63.6 69.0 27.8 91.0 45.3 93.9 63.0 88.3 30.9 86.4 29.8 87.0
Major, excl. mortality 71.6 74.3 38.4 92.1 63.0 68.8 27.0 91.0 45.9 94.0 63.0 88.6 31.5 86.4 29.3 87.3
Minor 41.8 69.3 37.0 73.4 44.4 67.6 38.1 73.1 11.5 85.9 25.9 69.2 22.2 86.3 42.1 71.2
Complication phenotypes
Hemi 82.5 71.2 23.9 97.4 55.2 65.6 12.7 94.2 55.0 91.2 40.7 94.9 27.6 84.7 14.0 92.8
Silent stroke 83.3 72.1 4.8 99.6 100.0 66.5 3.6 100.0 66.7 92.2 12.5 99.4 50.0 85.1 4.1 99.3
Pneumonia 100.0 73.8 8.0 100.0 100.0 67.3 3.8 100.0 25.0 92.6 7.1 98.2 75.0 85.9 6.4 99.6
Re-CRT/EI 21.4 73.6 3.3 95.8 54.5 68.1 5.9 97.6 21.4 93.2 11.5 96.6 9.1 85.7 2.3 96.3
SVD 45.8 78.7 31.8 87.0 43.6 71.7 26.1 84.7 11.9 95.2 35.0 83.3 21.8 88.3 30.0 83.1
Speech 44.0 81.0 19.0 93.5 39.1 72.8 13.2 91.9 8.0 95.5 15.4 91.1 21.7 89.4 17.9 91.5
Minor infections 36.8 82.5 14.9 94.0 50.0 74.6 13.6 94.9 5.3 95.6 9.1 92.4 37.5 91.5 26.1 94.8
Dysphagia 14.3 82.4 2.5 96.8 42.9 75.3 5.9 97.3 14.3 95.9 10.0 97.2 14.3 91.8 5.9 96.7
Sole complications
Hemi 78.6 82.5 22.4 98.4 63.6 75.8 13.2 97.3 50.0 96.3 46.7 96.8 18.2 91.6 11.1 95.1
Re-CRT/EI 12.5 82.5 2.6 96.2 50.0 75.8 8.0 97.3 12.5 96.3 11.1 96.8 12.5 91.6 5.9 96.1
SVD 42.5 82.5 30.9 88.6 45.9 75.8 27.0 87.8 10.0 96.3 33.3 85.3 24.3 91.6 36.0 86.1
Speech 31.3 82.5 11.6 94.2 28.6 75.8 8.0 93.5 0.0 96.3 0.0 92.9 14.3 91.6 11.1 93.5
Minor infections 36.8 82.5 15.6 93.7 50.0 75.8 14.8 94.7 5.3 96.3 11.1 92.1 37.5 91.6 27.3 94.6
Dysphagia 14.3 82.5 2.6 96.8 42.9 75.8 6.1 97.3 14.3 96.3 11.1 97.2 14.3 91.6 5.9 96.7
Low patient counts (<5 patients) made sensitivity, specificity, and positive-, and negative predictive values not applicable for AMI, PE, DVT, N. facialis, WI/meningitis, and unplanned cranial minor reoperation complication phenotypes or sole
complications, nor for pneumonia phenotype or silent stroke sole complication.
sens., sensitivity; spec., specificity; PPV, positive predictive value; NPV, negative predictive value, mRS, modified Rankin Scale; Hemi, new or worsened hemiparesis; Re-CRT; re-craniotomy; EI, endovascular intervention; SVD, subjective visual
disturbance; AMI, acute myocardial infarction; PE, pulmonary embolism; DVT, deep-vein thrombosis; N., nervus; WI, wound infection; incl., including; excl., excluding.
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